Article
Studies on natural killer cells in chronic myeloid leukemia patients in remission.
Neoplasma - 1 Jan 1990
Dabholkar M, Tatake R J, Advani S, Gangal S G
Abstract excerpt
In our earlier studies, the natural killer (NK) cell mediated cytotoxicity was found to be impaired in 55% of chronic myeloid leukemia (CML) patients in remission (low NK responders), while the rest exhibited normal range of cytotoxicity (normal NK responders). In the present investigations probable factors contributing to the impaired NK activity of low NK responder CML patients have been analyzed. Peripheral...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
